BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 7244951)

  • 1. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
    Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
    Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
    Christensen SB; Jansson C
    Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary carcinoma of the breast without axillary lymph node metastases.
    Fracchia AA; Rosen PP; Ashikari R
    Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The axillary lymph nodes in breast cancer. Seven years on.
    Steele RJ
    J R Coll Surg Edinb; 1983 Sep; 28(5):282-91. PubMed ID: 6358482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sentinel lymph node biopsy in breast carcinoma. Can removal of the sentinel node replace axillary dissection?].
    Schalhorn B
    Fortschr Med; 1999 Feb; 117(5):22. PubMed ID: 10095307
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.
    Rampaul RS; Dale OT; Mitchell M; Blamey RW; Macmillan RD; Robertson JF; Ellis IO
    Breast; 2008 Apr; 17(2):195-8. PubMed ID: 18164619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is axillary lymph node dissection necessary in routine management of breast cancer? No.
    Cady B
    Important Adv Oncol; 1996; ():251-65. PubMed ID: 8791141
    [No Abstract]   [Full Text] [Related]  

  • 20. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.